Results 131 to 140 of about 868 (155)
Some of the next articles are maybe not open access.
Journal of Clinical Oncology, 2021
e16183 Background: Significant advances have been made in the management of hepatocellular carcinoma (HCC) with the introduction of locoregional therapies including Theraspere, a treatment utilizing glass microspheres coated in radioactive yttrium-90 (Y-90).
Sarah Elizabeth Fenton +8 more
openaire +1 more source
e16183 Background: Significant advances have been made in the management of hepatocellular carcinoma (HCC) with the introduction of locoregional therapies including Theraspere, a treatment utilizing glass microspheres coated in radioactive yttrium-90 (Y-90).
Sarah Elizabeth Fenton +8 more
openaire +1 more source
Gastroenterology, 2015
A S L D A b st ra ct s 33% of the patients received at least annual surveillance at Mayo Clinic. 31.9% did not receive any imaging at Mayo Clinic. In an attempt to assess the proportion of patients who may have had additional outside imaging studies, we specifically reviewed the records of 25 patients who received 50-74% surveillance. For 23 (88%), the
Maheen Sheikh +3 more
openaire +1 more source
A S L D A b st ra ct s 33% of the patients received at least annual surveillance at Mayo Clinic. 31.9% did not receive any imaging at Mayo Clinic. In an attempt to assess the proportion of patients who may have had additional outside imaging studies, we specifically reviewed the records of 25 patients who received 50-74% surveillance. For 23 (88%), the
Maheen Sheikh +3 more
openaire +1 more source
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2009
Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery.
A, Riaz +3 more
openaire +1 more source
Locoregional therapies, such as transarterial chemoembolization, radioembolization and thermal ablation (e.g., radiofrequency ablation) are establishing their roles in the management of liver malignancies. With yYttrium-90 radioembolization therapy (90Y) radionuclide labeled microspheres are injected into the tumor feeding artery.
A, Riaz +3 more
openaire +1 more source
Issues in emerging health technologies, 2007
(1) Microspheres containing radioactive yttrium-90 (90Y) are infused into the hepatic artery. These deliver high doses of ionizing radiation to inoperable hepatocellular carcinoma, the most common type of primary liver cancer. (2) Limited evidence from several case series indicates that palliative therapy with 90Y microspheres may reduce tumour size ...
openaire +1 more source
(1) Microspheres containing radioactive yttrium-90 (90Y) are infused into the hepatic artery. These deliver high doses of ionizing radiation to inoperable hepatocellular carcinoma, the most common type of primary liver cancer. (2) Limited evidence from several case series indicates that palliative therapy with 90Y microspheres may reduce tumour size ...
openaire +1 more source
Cancer Biotherapy and Radiopharmaceuticals
Background: Selective internal radiation therapy (SIRT) using a suitable β − -emitting radionuclide is a promising treatment modality for unresectable liver carcinoma. Yttrium-90 ( 90 Y) [
K.V. Vimalnath +10 more
openaire +2 more sources
Background: Selective internal radiation therapy (SIRT) using a suitable β − -emitting radionuclide is a promising treatment modality for unresectable liver carcinoma. Yttrium-90 ( 90 Y) [
K.V. Vimalnath +10 more
openaire +2 more sources
Successful liver transplantation after embolization of hepatocellular carcinoma with Theraspheres
Journal of Gastrointestinal Surgery, 2005Dean Kim +5 more
openaire +1 more source
First Patient in Singapore Treated With TheraSphere Radioembolization Therapy
Journal of Clinical Engineering, 2015openaire +1 more source